
Selective binding of a monoclonal antibody to Aspergillus niger glucose oxidase by formaldehyde fixed human polymorphonuclear leukocytes
Author(s) -
Kalayci Omer,
Moallem Hamid,
Fikrig Senih,
Chice Seto,
Michl Josef
Publication year - 2000
Publication title -
cytometry
Language(s) - English
Resource type - Journals
eISSN - 1097-0320
pISSN - 0196-4763
DOI - 10.1002/(sici)1097-0320(20000401)39:4<260::aid-cyto3>3.0.co;2-m
Subject(s) - monoclonal antibody , microbiology and biotechnology , epitope , flow cytometry , antibody , antigen , biology , glucose oxidase , chemistry , immunology , biochemistry , enzyme
Background Many of the procedures used in handling neutrophils may affect the expression of surface antigens, and hence their quantitation by flow cytometry. Methods Because the enzyme glucose oxidase of Aspergillus niger is absent in human tissues, an IgM against it (mAb GO) was used as negative control in a study involving the normal expression of neutrophil specific BH2‐Ag in different age groups. Results When peripheral blood leukocytes (PBL) were freshly prepared, processed and stained with FITC‐mAb GO without fixation or when the cells were stained with FITC‐mAb GO prior to fixation with 2% formaldehyde, both median fluorescent intensity (MFI) and per cent of positively stained polymorphonuclear leukocytes (PMN) were similar to that obtained with a background sample without any antibody. However, when PBL were fixed after isolation with different concentrations of formaldehyde and for varying durations, MFI and per cent of positively stained PMN but not of monocytes or lymphocytes with FITC‐mAb GO increased in a time and concentration dependent manner. Saturation was achieved at a finite concentration of the antibody. In a competition assay unlabelled mAb GO reduced binding of FITC‐mAb GO to PMN by 79% and 95% at concentrations 100 and 200 times that of FITC labelled antibody, respectively. Conclusions These observations strongly suggest that formaldehyde fixation causes the expression or accessibility of an epitope on PMN that is specifically recognized by the mAb GO. Cytometry 39:260–265, 2000 © 2000 Wiley‐Liss, Inc.